News 2020

Dec 29, 2020
Mindset Further Expands Portfolio of Psychedelic Drug Candidates with Third U.S. Provisional Patent Application; 50 Total New Psychedelic Patent-Pending Compounds Synthesized
Mindset Further Expands Portfolio of Psychedelic Drug Candidates with Third U.S. Provisional Patent Application; 50 Total New Psychedelic Patent-Pending Compounds Synthesized
Dec 29, 2020
Dec 22, 2020
Mindset Pharma to Commence Trading on the CSE on December 23, 2020 Under the Symbol “MSET”
Mindset Pharma to Commence Trading on the CSE on December 23, 2020 Under the Symbol “MSET”
Dec 22, 2020
Dec 16, 2020
Mindset Pharma Announces Closing of Non-Brokered Private Placement, Increasing Aggregate Gross Proceeds Raised to $5,000,000
Mindset Pharma Announces Closing of Non-Brokered Private Placement, Increasing Aggregate Gross Proceeds Raised to $5,000,000
Dec 16, 2020
Dec 15, 2020
Mindset Pharma Announces Upsizing and Closing of $4.17 Million Brokered Private Placement Financing
Mindset Pharma Announces Upsizing and Closing of $4.17 Million Brokered Private Placement Financing
Dec 15, 2020
Nov 09, 2020
Mindset Pharma Closes Ontario Brain Institute Funding and Announces Private Placement Offering
Mindset Pharma Closes Ontario Brain Institute Funding and Announces Private Placement Offering
Nov 09, 2020
Oct 20, 2020
Mindset Pharma Commences In Vivo Program for Its Proprietary Next Generation Psychedelic Drug Candidates and Provides Corporate Update
Mindset Pharma Commences In Vivo Program for Its Proprietary Next Generation Psychedelic Drug Candidates and Provides Corporate Update
Oct 20, 2020
Sep 15, 2020
Mindset Pharma Inc. and North Sur Complete Combination; North Sur Changes Name to Mindset Pharma Inc.
Mindset Pharma Inc. and North Sur Complete Combination; North Sur Changes Name to Mindset Pharma Inc.
Sep 15, 2020
Aug 31, 2020
Mindset Pharma Announces Promising Test Results of its Novel and Proprietary Psilocybin-Inspired Compounds
Mindset Pharma Announces Promising Test Results of its Novel and Proprietary Psilocybin-Inspired Compounds
Aug 31, 2020
Jul 27, 2020
Mindset Pharma Files Groundbreaking Psychedelic Patents
Mindset Pharma Files Groundbreaking Psychedelic Patents
Jul 27, 2020
Jul 27, 2020
Mindset Pharma Announces Filing of Groundbreaking Psilocybin Synthesis Patent
Mindset Pharma Announces Filing of Groundbreaking Psilocybin Synthesis Patent
Jul 27, 2020
Jun 29, 2020
North Sur Resources and Mindset Pharma Announce Proposed Transaction to Accelerate Development of Medical Psychedelics Industry
North Sur Resources and Mindset Pharma Announce Proposed Transaction to Accelerate Development of Medical Psychedelics Industry
Jun 29, 2020
May 06, 2020
Mindset Pharma Synthesizes Second Generation Medicinal Psychedelic Compounds
Mindset Pharma Synthesizes Second Generation Medicinal Psychedelic Compounds
May 06, 2020
Apr 14, 2020
Mindset Pharma Begins Work with Leading R&D Contractor for Next-Generation Psychedelic Drugs
Mindset Pharma Begins Work with Leading R&D Contractor for Next-Generation Psychedelic Drugs
Apr 14, 2020
Feb 14, 2020
Mindset Completes Private Placement Financing
Mindset Completes Private Placement Financing
Feb 14, 2020
Feb 10, 2020
Mindset Pharma engages InterVivo Solutions for Initial Drug Analysis
Mindset Pharma engages InterVivo Solutions for Initial Drug Analysis
Feb 10, 2020
Subscribe for latest news